Linkou CGMHInternational Medicel CenterSite map

Update:2020/09/02

Primary appointment
Associate director, Department of Radiation Oncology,Chang Gung Memorial Hospital at Linkou
Associate professor, Department of Radiation Oncology, Chang Gung Memorial Hospital – Linkou Medical Center
 
Specialty
Clinical Radiation Oncology, Head and neck cancers, Nasopharyngeal cancer, Quality of life research, Molecular biology of cancers
Education
June 1998 MD Chung-San University, Taichung, Taiwan, R.O.C.
July 2004 – June 2005 Master. Graduate Institute of Clinical Medical Science , Chang Gung University, Taiwan, R.O.C.
July 2005 – February 2012 Ph.D Graduate Institute of Clinical Medical Science , Chang Gung University, Taiwan, R.O.C.
Academic appointment &Employment record
July 1997 ~ May 1998 Internship Chang Gung Memorial Hospital – Linkou Medical Center
July 1998 ~ June 2001 Residentship Department of Radiation Oncology Chang Gung Memorial Hospital – Linkou Medical Center
July 2001 ~ June 2002 Chief Residentship Department of Radiation Oncology Chang Gung Memorial Hospital – Linkou Medical Center
July 2002 ~ Dec 2002 Attending physician .Department of Radiation Oncology .Chang Gung Memorial Hospital – Linkou Medical Center
Jan 2003 ~ June 2003 Chief Attending physician Department of Radiation Oncology Lo-Tung Pohai Hospital, Taiwan.
July 2003 ~ June 2004 Chief Attending physician Department of Radiation Oncology Wei-Gong Memorial Hospital, Taiwan.
July 2004 ~ June 2008 Attending physician Department of Radiation Oncology Chang Gung Memorial Hospital – Linkou Medical Center
July 2008 ~ June 2010 Lecturer Attending physician Department of Radiation Oncology Chang Gung Memorial Hospital – Linkou Medical Center
June 2010 ~ present Assistant professor Attending physician Department of Radiation Oncology Chang Gung Memorial Hospital – Linkou Medical Center
Membership in Scientific and Medical Societies
Taiwan Society for Therapeutic Radiology and Oncology
Publication
  • Lapke N, Lu YJ, Liao CT, Lee LY, Lin CY, Wang HM, Ng SH, Chen SJ, Yen TC. (2016, 06) Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma. Oncotarget. 2016 Jun 8. doi: 10.18632/oncotarget.9925. [Epub ahead of print]
  • Chiang CH, Wu CC, Lee LY, Li YC, Liu HP, Hsu CW, Lu YC, Chang JT*, Cheng AJ*. (2016, 9) Proteomics Analysis Reveals Involvement of Krt17 in Areca Nut-Induced Oral Carcinogenesis. J Proteome Res. 15(9):2981-97. doi: 10.1021/acs.jproteome.6b00138. Epub 2016 Aug 4.
  •  Huang BS, Chen WY, Hsieh CE, Lin CY, Lee LY, Fang KH, Tsang NM, Kang CJ, Wang HM, Chang JT*. (2016, 9) Outcomes and prognostic factors for surgery followed by modern radiation therapy in parotid gland carcinomas. Jpn J Clin Oncol. 46(9):832-8. doi: 10.1093/jjco/hyw067. Epub 2016 Jun 17.
  • Chang C, Lin WN, Hsin LJ, Lee LA, Lin CY, Li HY, Liao CT, Fang TJ. (2016, 4) Reliability of office-based narrow-band imaging-guided flexible laryngoscopic tissue samplings. Laryngoscope. 2016 Apr 23. doi: 10.1002/lary.26016. [Epub ahead of print]
  • Wang HM, Lin CY, Hsieh CH, Hsu CL, Fan KH, Chang JT, Huang SF, Kang CJ, Liao CT, Ng SH, Yen TC. (2016, 4) Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer. J Formos Med Assoc. 2016 Apr 25. pii: S0929-6646(16)30015-8. doi: 10.1016/j.jfma.2016.03.005. [Epub ahead of print]
  • Hsieh CE, Lin CY*, Lee LY, Yang LY, Wang CC, Wang HM, Chang JT, Fan KH, Liao CT, Yen TC, Fang KH, Tsang YM*. (2016, 3) Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study. Radiat Oncol. 2016 Mar 22;11(1):47. doi: 10.1186/s13014-016-0617-7.(共同責任作者)
  • Adel M, Liao CT, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, Huang SF, Kang CJ, Fang KH, Wang YC, Chang KP, Fang TJ, Yang LY, Yen TC. (2016, 3) Incidence and Outcomes of Patients With Oral Cavity Squamous Cell Carcinoma and Fourth Primary Tumors: A Long-term Follow-up Study in a Betel Quid Chewing Endemic Area. Medicine (Baltimore). 95(12):e2950. doi: 10.1097/MD.0000000000002950.
  • Chen SH, Wang HM, Lin CY, Chang JT, Hsieh CH, Liao CT, Kang CJ, Yang LY, Yen TC. (2016, 2) RGD-K5 PET/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: Results from a pilot study. Eur J Nucl Med Mol Imaging. 2016 Feb 27. [Epub ahead of print]
  • Liao CT, Kang CJ, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, Fang TJ, Huang SF, Chang KP, Chang YL, Yang LY, Yen TC. (2016, 2) Association between multidisciplinary team care approach and survival rates in patients with oral cavity squamous cell carcinoma. Head Neck. 2016 Feb 18. doi: 10.1002/hed.24276. [Epub ahead of print]
  • Liao CT, Chen SJ, Lee LY, Hsueh C, Yang LY, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, Chen IH, Chang KP, Huang SF, Kang CJ, Chen HC, Yen TC. (2016, 2) An Ultra-Deep Targeted Sequencing Gene Panel Improves the Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma. Medicine (Baltimore). 2016 Feb;95(8):e2751. doi: 10.1097/MD.0000000000002751.
  • Ng SH, Liao CT, Lin CY, Chan SC, Lin YC, Yen TC, Chang JT, Ko SF, Fan KH, Wang HM, Yang LY, Wang JJ. (2016, 2) Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. Eur Radiol. 2016 Feb 24. [Epub ahead of print]
  • Chin SC, Lin CY, Huang BS, Tsang NM, Fan KH, Ku YK, Hsu CL, Chan SC, Huang SF, Li CH, Tseng HJ, Liao CT, Liu HL, Sung K. (2016, 2) Pretreatment Dynamic Contrast-Enhanced MRI Improves Prediction of Early Distant Metastases in Patients With Nasopharyngeal Carcinoma. Medicine (Baltimore). 95(6):e2567. doi: 10.1097/MD.0000000000002567.
  • Lee LA, Huang CG, Tsao KC, Liao CT, Kang CJ, Chang KP, Huang SF, Chen IH, Fang TJ, Li HY, Yang SL, Lee LY, Hsueh C, Lin CY, Fan KH, Chang TC, Wang HM, Ng SH, Yen TC. (2015, 11) Human Papillomavirus Infections are Common and Predict Mortality in a Retrospective Cohort Study of Taiwanese Patients With Oral Cavity Cancer. Medicine (Baltimore). 94(47):e2069. doi: 10.1097/MD.0000000000002069.
  • Liao CT, Fan KH, Kang CJ, Lin CY, Chang JT, Tsang NM, Huang BS, Chao YK, Lee LY, Hsueh C, Wang HM, Liau CT, Hsu CL, Hsieh CH, Ng SH, Lin CH, Tsao CK, Fang TJ, Huang SF, Chang KP, Yen TC. (2015, 9) Clinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary Malignancies. PLoS One. 10(9): e0136918.
  • Chen SC*, Lai YH, Huang BS, Lin CY, Fan KH, Chang JT. (2015, 6) Changes and predictors of radiation-induced oral mucositis in patients with oral cavity cancer during active treatment. Eur J Oncol Nurs. 19(3):214-9.
  • Kang CJ, Lin CY, Yang LY, Ho TY, Lee LY, Fan KH, Wang HM, Huang SF, Chang KP, Fang KH, Ng SH, Liao CT*, Yen TC*. (2015, 1) Positive Clinical Impact of an Additional PET/CT Scan Before Adjuvant Radiotherapy or Concurrent Chemoradiotherapy in Patients with Advanced Oral Cavity Squamous Cell Carcinoma. J Nucl Med. 56(1):22-30.(共同第一作者)
  • Huang SF, Tung-Chieh Chang J, Liao CT, Kang CJ, Lin CY, Fan KH, Wang HM, Chen IH. (2015, 1) The role of elective neck dissection in early stage buccal cancer. Laryngoscope. 125(1):128-33.
  • Ng SH, Lin CY, Chan SC, Lin YC, Yen TC, Liao CT, Chang JT, Ko SF, Wang HM, Chang CJ, Wang JJ. (2014, 12) Clinical Utility of Multimodality Imaging with Dynamic Contrast-Enhanced MRI, Diffusion-Weighted MRI, and 18F-FDG PET/CT for the Prediction of Neck Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiation. PLoS One. 9(12):e115933.
  • Huang CG, Lee LA, Tsao KC, Liao CT, Yang LY, Kang CJ, Chang KP, Huang SF, Chen IH, Yang SL, Lee LY, Hsueh C, Chen TC, Lin CY, Fan KH, Chang TC, Wang HM, Ng SH, Yen TC. (2014, 10) Human papillomavirus 16/18 E7 viral loads predict distant metastasis in oral cavity squamous cell carcinoma. J Clin Virol. 61(2):230-6.
  • Liao CT, Wallace CG, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, Chen IH, Huang SF, Kang CJ, Yen TC. (2014, 8) Clinical evidence of field cancerization in patients with oral cavity cancer in a betel quid chewing area. Oral Oncol. 50(8):721-31.
  •  Wang HM, Hsu CL, Hsieh CH, Fan KH, Lin CY, Chang JT, Huang SF, Chen IH, Liao CT, Ng SK. (2014, 5-6) Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx. Biomed J. 37(3):133-40.
  • Chen SC, Lai YH, Liao CT, Huang BS, Lin CY, Fan KH, Chang JT. (2014, 5) Unmet supportive care needs and characteristics of family caregivers of patients with oral cancer after surgery. Psychooncology. 23(5):569-77.
  • Lin CH, Kang CJ, Tsao CK, Wallace CG, Lee LY, Lin CY, Wang HM, Ng SH, Yen TC, Liao CT. (2014, 4) Priority of fibular reconstruction in patients with oral cavity cancer undergoing segmental mandibulectomy. PLoS One. 9(4):e94315.
  • Fang YH, Lin CY, Shih MJ, Wang HM, Ho TY, Liao CT, Yen TC. (2014, 3) Development and evaluation of an open-source software package "CGITA" for quantifying tumor heterogeneity with molecular images. Biomed Res Int. 2014:248505. doi: 10.1155/2014/248505. Epub 2014 Mar 17.
  • Hung TM, Chen CC, Lin CY, Ng SH, Kang CJ, Huang SF, Liao CT, Fan KH, Wang HM*, Chang JT*. (2014, 3) Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy. Oral Oncol. 50(3):228-33.
  • Fan KH, Lin CY, Kang CJ, Lee LY, Huang SF, Liao CT, Chen IH, Ng SH, Wang HM, Chang JT. (2014, 2) Postoperative concomitant chemoradiotherapy improved treatment outcomes of patients with oral cavity cancer with multiple-node metastases but no other major risk factors. PLoS One. 9(2):e86922.
  • Tseng JR, Ho TY, Lin CY, Lee LY, Wang HM, Liao CT, Yen TC. (2013, 11) Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT. PLoS One. 8(11):e79766.
  • Chan SC*, Kuo WH, Wang HM, Chang JT, Lin CY, Ng SH, Hsu CL, Chang KP, Liao CT, Lin YJ, Yen TC. (2013, 10) Prognostic implications of post-therapy 18F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. Ann Nucl Med. 27(8):710-9.
  • Cheng NM, Fang YH, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Lin CY, Liao CT, Yen TC*. (2013, 10) Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma. J Nucl Med. 54(10):1703-9.
  • Lee LA, Huang CG, Tsao KC, Liao CT, Kang CJ, Chang KP, Huang SF, Chen IH, Fang TJ, Li HY, Yang SL, Lee LY, Hsueh C, Chen TC, Lin CY, Fan KH, Wang HM, Ng SH, Chang YL, Lai CH, Shih SR, Yen TC. (2013, 8) Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes. J Clin Virol. 57(4):331-7.
  • Ng SH, Lin CY, Chan SC, Yen TC, Liao CT, Chang JT, Ko SF, Wang HM, Huang SF, Lin YC, Wang JJ. (2013, 8) Dynamic Contrast-Enhanced MR Imaging Predicts Local Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiotherapy. PLoS One. 8(8):e72230.
  • Chen HH, Wang HM, Fan KH, Lin CY, Yen TC, Liao CT, Chen IH, Kang CJ, Huang SF. (2013, 8) Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma. PLoS One. 8(1):e55327.
  • Chen SC, Lai YH, Liao CT, Chang JT, Lin CY, Fan KH, Huang BS. (2013, 6) Supportive care needs in newly diagnosed oral cavity cancer patients receiving radiation therapy. Psychooncology. 22(6):1220-8.
  • Hsu CL, Chan SC, Chang KP, Lin TL, Lin CY, Hsieh CH, Huang SF, Tsang NM, Lee LY, Ng SH, Wang HM. (2013, 6) Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma.. Oral Oncol. 49(6):620-5.
  • Liao CT, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, Chen IH, Chang KP, Huang SF, Kang CJ, Fang KH, Wang YC, Chang YL, Huang YC, Tsai CY, Yen TC. (2013, 3) Comparative outcomes in oral cavity cancer with resected pT4a and pT4b. Oral Oncol. 49(3):230-6.
  • Hung TM, Wang HM, Kang CJ, Huang SF, Liao CT, Chan SC, Ng SH, Chen IH, Lin CY, Fan KH, Chang JT. (2013, 2) Pretreatment (18)F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma. Oral Oncol. 49(2):169-74.
  • Chen HH, Wang HM, Fan KH, Lin CY, Yen TC, Liao CT, Chen IH, Kang CJ, Huang SF. (2013, 2) Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma. PLoS One. 2013;8(1):e55327.
  • Liao CT, Lin CY, Fan KH, Hsueh C, Lee LY, Wang HM, Huang SF, Chen IH, Kang CJ, Ng SH, Lin CH, Huang YC, Yen TC. (2013, 1) Outcome Analyses of Unusual Site Neck Recurrence in Oral Cavity Cancer. Ann Surg Oncol. 20(1):257-66.
  • Tsan DL, Lin CY, Kang CJ, Huang SF, Fan KH, Liao CT, Chen IH, Lee LY, Wang HM, Chang JT*. (2012,12) The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity. Radiat Oncol. 18;7(1):215.
  • Cheng NM, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Liao CT, Lin CY, Hsu CL, Yen TC. (2012, 11) Prognostic value of pretreatment (18)F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 39(11):1673-84.
  • Chan SC, Wang HM, Ng SH, Hsu CL, Lin YJ, Lin CY, Liao CT, Yen TC. (2012, 11) Utility of 18F-Fluoride PET/CT and 18F-FDG PET/CT in the Detection of Bony Metastases in Heightened-Risk Head and Neck Cancer Patients. J Nucl Med. 2012 Sep 7. 53(11):1730-5.
  • Huang SF, Wei FC, Liao CT, Wang HM, Lin CY, Lo S, Huang JJ, Chen IH, Kang CJ, Chien HT, Chen HH. (2012, 11) Risk Stratification in Oral Cavity Squamous Cell Carcinoma by Preoperative CRP and SCC Antigen Levels. Ann Surg Oncol. 19(12):3856-64.
  • Luo CM, Fang TJ, Lin CY, Chang JT, Liao CT, Chen IH, Li HY, Chiang HC. (2012, 9) Transoral Laser Microsurgery Elevates Fundamental Frequency in Early Glottic Cancer. J Voice. 26(5):596-601.
  • Hsu CL, Chang KP, Lin CY, Chang HK, Wang CH, Lin TL, Liao CT, Tsang NM, Lee LY, Chan SC, Ng SH, Li HP, Chang YS, Wang HM. (2012, 8) Plasma epstein-barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma. Head Neck. 34(8):1064-70.
  • Lee LA, Huang CG, Liao CT, Lee LY, Hsueh C, Chen TC, Lin CY, Fan KH, Wang HM, Huang SF, Chen IH, Kang CJ, Ng SH, Yang SL, Tsao KC, Chang YL, Yen TC. (2012, 7) Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One. 2012;7(7):e40767.
  • Liao CT, Fan KH, Lin CY, Wang HM, Huang SF, Chen IH, Kang CJ, Ng SH, Hsueh C, Lee LY, Lin CH, Yen TC. (2012, 6) Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread. Eur J Nucl Med Mol Imaging. 39(6):944-55.
  • Liao CT, Lin CY, Fan KH, Wang HM, Ng SH, Lee LY, Hsueh C, Chen IH, Huang SF, Kang CJ, Yen TC. (2012, 6) Identification of a High-Risk Group Among Patients With Oral Cavity Squamous Cell Carcinoma and pT1-2N0 Disease. Int J Radiat Oncol Biol Phys. 1;82(1):284-90.
  • Kang CJ, Liao CT, Hsueh C, Lee LY, Lin CY, Fan KH, Wang HM, Huang SF, Chen IH, Ng SH, Tsao CK, Huang YC, Yen TC. (2011, 11) Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma. Oral Oncol. 47(11):1085-91.
  • Kang CJ, Lin CY, Wang HM, Fan KH, Ng SH, Lee LY, Chen IH, Huang SF, Liao CT, Yen TC.(2011, 11) The Number of Pathologically Positive Lymph Nodes and Pathological Tumor Depth Predicts Prognosis in Patients with Poorly Differentiated Squamous Cell Carcinoma of the Oral Cavity. Int J Radiat Oncol Biol Phys. 15;81(4):e223-30.
  • Liao CT, Lee LY, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Yen TC. (2011, 11) Outcome Analysis of Patients with Oral Cavity Cancer and Extracapsular Spread in Neck Lymph Nodes. Int J Radiat Oncol Biol Phys. 15;81(4):930-7.
  • Chan SC, Chang JT, Lin CY, Ng SH, Wang HM, Liao CT, Chang CJ, Lin SY, Yen TC. (2011, 11) Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification. Nucl Med Commun. 32(11):989-96.
  • Lin CY, Lin TY, Wang HM, Huang SF, Fan KH, Liao CT, Chen IH, Lee LY, Li YL, Chen YJ, Cheng AJ*, Chang JT*. (2011, 10) GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapy. Radiat Oncol. 12;6(1):136.
  • Liao CT,Lin CY , Fan KH, Huang SF, Chen IH, Kang CJ, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Yen TC. (2011, 9) Identification of a High-Risk Subgroup of Patients with Resected pT3 Oral Cavity Cancer in Need of Postoperative Adjuvant Therapy. Ann Surg Oncol. 18(9):2569-78.
  • Chan SC, Wang HM, Yen TC, Lin CY, Chin SC, Liao CT, Wai YY, Wang JJ, Ng SH. (2011, 9) (18)F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study. Eur J Nucl Med Mol Imaging. 38(9):1607-19.
  • Chiu CC, Lin CY, Lee LY, Chen YJ, Lu YC, Wang HM, Liao CT, Chang JT, Cheng AJ. (2011, 7) Molecular Chaperones as a Common Set of Proteins That Regulate the Invasion Phenotype of Head and Neck Cancer. Clin Cancer Res. 15;17(14):4629-41.
  • Ng SH, Chan SC, Yen TC, Liao CT, Lin CY, Tung-Chieh Chang J, Ko SF, Wang HM, Chang KP, Fan KH. (2011, 6)PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma. Eur J Nucl Med Mol Imaging.38(6):996-1008.
  • Abd El-Hafez YG, Chen CC, Ng SH, Lin CY, Wang HM, Chan SC, Chen IH, Huan SF, Kang CJ, Lee LY, Lin CH, Liao CT, Yen TC. (2011, 4) Comparison of PET/CT and MRI for the detection of bone marrow invasion in patients with squamous cell carcinoma of the oral cavity. Oral Oncol. 47(4):288-95.
  • Liao CT, Wang HM, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Ng SH, Hsueh C, Lee LY, Lin CH, Yen TC. (2011, 2) PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity. J Nucl Med. 52(2):180-7.
  • Liao CT, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Yen TC. (2010, 11) Tongue and Buccal Mucosa Carcinoma: Is There a Difference in Outcome? Ann Surg Oncol. 17:2984-91.
  • Lin CY, Wang HM, Kang CJ, Lee LY, Huang SF, Fan KH, Chen EYC, Chen IH, Liao CT, Chang JT*. (2010, 11) Primary tumor site as a predictor of treatment outcome for definitive radiotherapy of advanced stage oral cavity cancers. Int J Radiat Oncol Biol Phys. 78(4):1011-9. (SCI)
  • Chang MF, Wang HM, Kang CJ, Huang SF, Lin CY, Fang KH, Chen EY, Chen IH, Liao CT, Chang JT*. (2010, 10) Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary--an experience in Taiwan. Radiat Oncol. 5:91.
  • Lin TY, Chang JT, Wang HM, Chan SH, Chiu CC, Lin CY, Fan KH, Liao CT, Chen IH, Liu TZ, Li HF, Cheng AJ.(2010, 9) Proteomics of the Radioresistant Phenotype in Head-and-Neck Cancer: Gp96 As a Novel Prediction Marker and Sensitizing Target for Radiotherapy. Int J Radiat Oncol Biol Phys. 78:246-56. (SCI; IF=4.639; Radiology, Nuclear Med. &Med Imaging 7/90)
  • Ng SH, Chan SC, Yen TC, Liao CT, Chang JT, Ko SF, Wang HM, Lin CY, Chang KP, Lin YC. (2010, 9) Comprehensive imaging of residual/recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT. Eur Radiol.  20:2229-40.
  • Lin CY, Chen WH, Liao CT, Chen IH, Chiu CC, Lee LY, Wang HM, Chang JT, Yen TC, Cheng AJ. (2010, 8) Positive association of GRP78 during oral cancer progression and the prognostic value in oral precancer lesions. Head Neck. 32:1028-39 (SCI; IF=2.603; Otorhinolaryngology 1/31 )
  • Fan KH, Wang HM, Kang CJ, Lee LY, Huang SF, Lin CY, Chen EY, Chen IH, Liao CT, Chang JT. (2010, 7) Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates. Int J Radiat Oncol Biol Phys. 77:1024-9. (SCI; IF=4.639; Radiology, Nuclear Med. &Med Imaging 7/90)
  • Liao CT, Wang HM, Chang JT, Lin CY, Ng SH, Huang SF, Chen IH, Hsueh C, Lee LY, Lin CH, Cheng AJ, Yen TC. (2010, 6) Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 77:421-9. (SCI; IF=4.639; Radiology, Nuclear Med. &Med Imaging 7/90)
  • Liao CT, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Hsueh C, Lee LY, Tsao CK, Yen TC. (2010, 4) Outcome Analysis of Patients with pN2 Oral Cavity Cancer. Ann Surg Oncol. 17:1118-26.
  • Chang JT, Lin CY, Lin JC, Lee MS, Chen YJ, Wang HM. (2010, 4) Transdermal Fentanyl for Pain Caused by Radiotherapy in Head and Neck Cancer Patients Treated in an Outpatient Setting: A Multicenter Trial in Taiwan. Jpn J Clin Oncol. 40:307-12
  • Chan SC, Lin CY, Ng SH, Chang JT, Wang HM, Liao CT, Lo CW, Yen TC. (2010, 3) 18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis. Nucl Med Commun. 31:260-5.(SCI)
  • Wu YH, Wang HM, Hi-Wen Chen H, Lin CY, Yen-Chao Chen E, Fan KH, Huang SF, Chen IH, Liao CT, Cheng AJ, Chang JT. (2010, 3) Hypothyroidism after radiotherapy for nasopharyngeal cancer patients. Int J Radiat Oncol Biol Phys. 76:1133-9 (SCI; IF=4.639; Radiology, Nuclear Med. &Med Imaging 7/90)
  • Kang CJ, Chen YJ, Liao CT, Wang HM, Chang JT, Lin CY, Lee LY, Wang TH, Yen TC, Shen CR, Chen IH, Chiu CC, Cheng AJ. (2009, 11) Transcriptome profiling and network pathway analysis of genes associated with invasive phenotype in oral cancer. Cancer Lett. 284:131-40. (SCI; IF=3.504; Oncology 36/141)
  • Hung TM, Hong JH, Leung WM, Lin CY, Tsan DL, Tsang NM. Radiation Therapy for Advanced Hepatocellular Carcinoma with Hepatic Hilum Involvement and High Bilirubin Level: Better Survival in Decreased Bilirubin after Radiotherapy . Therapeut Radiol Oncol 16(3) 179-194
  • Ng SH, Chan SC, Liao CT, Chang JT, Ko SF, Wang HM, Chin SC, Lin CY, Huang SF, Yen TC. (2008, 11) Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18) F-FDG PET and extended-field multi-detector row CT. Neuroradiology. 50:969-79. (SCI; IF=2.029; Radiology, Nuclear Med. &Med Imaging 43/90)
  • Chiu CC, Lin CY, Lee LY, Chen YJ, Kuo TF, Chang JT, Liao CT, Wang HM, Yen TC, Shen CR, Liao SK, Cheng AJ. (2008, 9) Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention. Mol Cancer Ther. 7: 2788-97 (SCI; IF=5.003; Oncology 24/141 )
  • Chang JT, Chang CH, Juang YY, Hsiao JC, Lin CY, Huang SF, Huang YC, Kuan KH, Liao CT, Wang HM, Chen IH. (2008, 7) Internal consistency of the traditional Chinese character version of the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N). Chang Gung Med J. 31(4):384-94
  • Chan SC, Chang JT, Wang HM, Lin CY, Ng SH, Fan KH, Chin SC, Liao CT, Yen TC. (2008, 5) Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: The role of standardized uptake value. Oral Oncol. 45:52-8. (SCI; IF=2.928; Dentistry Oral 5/55)
  • Lin CY, Li YL, Huang SF, Kang CJ, Fan KH, Wang HM, Chen YC, Chen IH, Liao CT, Cheng AJ, Chang JT. (2008, 4) Treatment outcome of combined modalities for buccal cancers - unilateral or bilateral neck radiation? Int J Radiat Oncol Biol Phys. 70: 1373-81 (SCI; IF=4.639; Radiology, Nuclear Med. &Med Imaging 7/90)
  • Huang SF, Kang CJ, Lin CY, Fan KH, Yen TC, Wang HM, Chen IH, Liao CT, Cheng AJ, Chang JT. (2008, 3) Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection. Cancer 112: 1066-75 (SCI; IF=5.238; Oncology 19/141)
  • Liu FY, Lin CY, Chang JT, Ng SH, Chin SC, Wang HM, Liao CT, Chan SC, Yen TC.  (2007, 10) 18F-FDG PET Can Replace Conventional Work-up in Primary M Staging of Nonkeratinizing Nasopharyngeal Carcinoma. J Nucl Med. 48:1614-1619 (SCI; IF=6.662; Radiology, Nuclear Med. &Med Imaging 1/90)
  • Chang JT, Chen CJ, Lin YC, Chen YC, Lin CY, Cheng AJ. (2007, 9) Health-related quality of life and patient satisfaction after treatment for breast cancer in northern Taiwan. Int J Radiat Oncol Biol Phys. 69:49-53. (SCI; IF=4.639; Radiology, Nuclear Med. &Med Imaging 7/90)
  • Chang JT, Chan SH, Lin CY, Lin TY, Wang HM, Liao CT, Wang TH, Lee LY, Cheng AJ. (2007, 8) Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol Cancer Ther. 6: 2271-9 (SCI; IF=5.003; Oncology 24/141 )
  • Fan KH, Lin CY, Kang CJ, Huang SF, Wang HM, Chen EY, Chen IH, Liao CT, Cheng AJ, Chang JT. (2007, 2) Combined-modality treatment for advanced oral tongue squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 67: 453-61 (SCI; IF=4.639; Radiology, Nuclear Med. &Med Imaging 7/90)
  • Chan SC, Yen TC, Ng SH, Lin CY, Wang HM, Liao CT, Fan KH, Chang JT. (2006, 9) Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management. J Nucl Med. 47:1447-54. (SCI; IF=6.662; Radiology, Nuclear Med. &Med Imaging 1/90)
  • Chan SC, Ng SH, Chang JT, Lin CY, Chen YC, Chang YC, Hsu CL, Wang HM, Liao CT, Yen TC. (2006, 9) Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 33: 1032-40. (SCI; IF=4.532; Radiology, Nuclear Med. &Med Imaging  8/90)
  • Yen TC, Lin CY, Wang HM, Huang SF, Liao CT, Kang CJ, Ng SH, Chan SC, Fan KH, Chen IH, Lin WJ, Cheng AJ, Chang JT. (2006, 2) 18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity modulated radiation technique for stage T4 nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 65:1307-14 (SCI; IF=4.639; Radiology, Nuclear Med. &Med Imaging 7/90)
  • Chang JT, Lin CY, Chen TM, Kang CJ, Ng SH, Chen IH, Wang HM, Cheng AJ, Liao CT. (2005, 12) Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy. Int J Radiat Oncol Biol Phys. 63:1354-60 (SCI; IF=4.639; Radiology, Nuclear Med. &Med Imaging 7/90)
  • Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Lin KJ, Lin WJ, Fu YK, Lin CY. (2005, 3). The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med. 46:405-10. (SCI; IF=6.662; Radiology, Nuclear Med. &Med Imaging 1/90)
  • Chang JT, Chan SC, Yen TC, Liao CT, Lin CY, Chen IH, Wang HM, Chang YC, Chen TM, Kang CJ, Ng SH. (2005, 1) Nasopharyngeal carcinoma staging PDG PET. Int J Radiat Oncol Biol Phys 30:501-06 (SCI; IF=4.639; Radiology, Nuclear Med. &Med Imaging 7/90)
  • Liao CT, Chang JT, Wang HM, Chen IH, Lin CY, Chen TM, Hsieh LL, Cheng AJ. (2004, 6) Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma. Head Neck 26: 504-12 (SCI; IF=2.603; Otorhinolaryngology 1/31 ).
  • Tsang NM, Chuang CC, Tseng CK, Hao SP, Kuo TT, Lin CY, Pai PC. (2003, 9) Presence of the latent membrane protein 1 Gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma. Cancer 98: 2385-92 (SCI; IF=5.238; Oncology 19/141)
  • Tsang NM, Fan KH, Pai PC, Tsai CS, Lin CY, Chen CY, Tseng CK. (2003, 3) The Effect of Fixed Couch-Isocenter Distance Treatment on Radiotherapy in Rectal Cancer Patients. Therapeut Radiol Oncol 10:1, 37-44
  • Huang YT, Pai PC, Tseng CK, Lin CY, Hong JH, Tsang NM. (2003, 6) The outcome of patients with nasopharyngeal carcinoma treated with suboptimal radiation dose. Therapeut Radiol Oncol 10:2:63-68
  • Ho CJ, Ro CR, Chen YC, Cheng AJ, Tseng CK, Lin CY, Chang JT. (2001, 3) Intracavity Brachytherapy for nasopharyngeal carcinoma with Rotterdam Nasopharyngeal Applicator. Therapeut Radiol Oncol 8:1:33-41
  • Lin CY, Li SH, Chen LH, Hong JH, Chang JT. (2000, 6) Junction techniques for pharynx and neck treatment. Therapeut Radiol Oncol 7: 77-87

Presentations:

  • Lin CY. (2013, 11) Evolutions of postoperative radiotherapy in oral cavity cancers – Dependence on Post-OP/Pre-RT 18F-FDG-PET/CT scan image findings. The First Global Conference of Chinese Professionals in Nuclear Medicine and Molecular Imaging (1st GCCPNMMI), Xiamen, China.
  • Lin CY. (2013, 4) The patient cares for Head and Neck cancers under proton therapy in the future. Nurse teaching program in department of Radiation Oncology – Linkou Chang Gung Memorial Hospital
  •  Lin CY. (2013, 1) Evolutions of postoperative RT in oral cavity cancer patients - dependence on Pre-RT F18-FDG-PET scan. The resident teaching program in Nuclear Medicine Society.
  • Lin CY, et al. (2012, 12) The impact of dose-painting on patients with unresectable oral cavity cancer treated by IMRT using the SIB technique. Academic Conference of TASTRO & the Second Annual Meeting of TAROS